English
  • head_banner_01
Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex Featured Image
  • Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex

Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex

Short Description:


Product Detail

Product Tags

Related Video

Feedback (2)

Our primary goal is to offer our clients a serious and responsible business relationship, providing personalized attention to all of them for Acetyl Tributyl Citrate 77-90-7, Raw Material, Nafcillin Sodium, Wanting on the long run, a protracted way to go, continually striving to become the all team with full enthusiasm, one hundred times the confidence and put our company created a beautiful environment, advanced merchandise, good quality first-class modern business and get the job done hard!
Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex Detail:

Product Detail

Name  Leuprorelin
CAS number  53714-56-0
Molecular formula  C59H84N16O12
Molecular weight  1209.4
EINECS Number  633-395-9
Specific rotation  D25 -31.7° (c = 1 in 1% acetic acid)
Density  1.44±0.1 g/cm3(Predicted)
Storage condition  -15°C
Form  Neat
Acidity coefficient  (pKa) 9.82±0.15 (Predicted)
Water solubility  Soluble in water at 1mg/ml

Synonyms

LH-RHLEUPROLIDE;LEUPROLIDE;LEUPROLIDE(HUMAN);LEUPRORELIN;[DES-GLY10,D-LEU6,PRO-NHET9]-LUTEINIZINGHORMONE-RELEASINGHORMONEHUMAN;(DES-GLY10,D-LEU6,PRO-NHET9)-LUTEINIZINGHORMONE-RELEASINGHORMONE;(DES-GLY10,D-LEU6,PRO-NHET9)-LUTEINIZINGHORMONE-RELEASINGFACTOR;[DES-GLY10,D-LEU6,PRO-NHET9]-LH-RH(HUMAN)

Pharmacological Effect

Leuprolide, goserelin, triprelin, and nafarelin are several drugs commonly used in clinical practice to remove ovaries for the treatment of premenopausal breast cancer and prostate cancer. (referred to as GnRH-a drugs), GnRH-a drugs are similar in structure to GnRH and compete with pituitary GnRH receptors. That is, the gonadotropin secreted by the pituitary decreases, which leads to a significant decrease in the sex hormone secreted by the ovary.

Leuprolide is a gonadotropin-releasing hormone (GnRH) analog, a peptide composed of 9 amino acids. This product can effectively inhibit the function of the pituitary-gonadal system, the resistance to proteolytic enzymes and the affinity to the pituitary GnRH receptor are stronger than GnRH, and the activity of promoting the release of luteinizing hormone (LH) is about 20 times that of GnRH. It also has a stronger inhibitory effect on pituitary-gonad function than GnRH. In the initial stage of treatment, follicle stimulating hormone (FSH), LH, estrogen or androgen may be temporarily increased, and then, due to the decreased responsiveness of the pituitary gland, the secretion of FSH, LH and estrogen or androgen is inhibited, resulting in dependence on sex hormones. Sexual diseases (such as prostate cancer, endometriosis, etc.) have a therapeutic effect.

At present, the acetate salt of leuprolide is mainly used clinically, because the performance of leuprolide acetate is more stable at room temperature. Liquid should be discarded. It can be used for the drug castration treatment of endometriosis and uterine fibroids, central precocious puberty, premenopausal breast cancer and prostate cancer, and also for functional uterine bleeding that is contraindicated or ineffective for conventional hormone therapy. It can also be used as a premedication before endometrial resection, which can evenly thin the endometrium, reduce edema, and reduce the difficulty of surgery.

Product detail pictures:

Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex detail pictures

Related Product Guide:
We're committed to furnishing easy,time-saving and money-saving one-stop purchasing support of consumer for Factory making N-Methyl-N-((3r,4r)-4-Methylpiperidin-3-Yl)-7h-Pyrrolo[2,3-D]Pyrimidin-4-Amine - Orlistat 96829-58-2 Reducing Absorption of Sietary Fat, Resulting in Weight Loss – Gentolex , The product will supply to all over the world, such as: Greece, Vietnam, Monaco, What is good price? We provide customers with factory price. In the premise of good quality, efficiency must be paid attention to and maintain appropriate low and healthy profits. What is a fast delivery? We make the delivery according to customers' requirements. Although delivery time depends on the order quantity and the complexity of it, we still try to supply products in time. Sincerely hope we could have long term business relationship.
    • The sales manager has a good English level and skilled professional knowledge, we have a good communication. He is a warm and cheerful man, we have a pleasant cooperation and we became very good friends in private.
    5 Stars By Ina from Ghana - 2017.05.02 18:28
    The factory can meet continuously developing economic and market needs, so that their products are widely recognized and trusted, and that's why we chose this company.
    5 Stars By Katherine from Finland - 2018.10.01 14:14
    Write your message here and send it to us

    Related PRODUCTS

    Hit enter to search or ESC to close